nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comprehensive approach to reablement in dementia
|
Poulos, Christopher J. |
|
2017 |
|
3 |
p. 450-458 9 p. |
artikel |
2 |
Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab
|
Samtani, Mahesh N. |
|
2015 |
|
3 |
p. 157-169 13 p. |
artikel |
3 |
Alzheimer's disease drug development pipeline: 2017
|
Cummings, Jeffrey |
|
2017 |
|
3 |
p. 367-384 18 p. |
artikel |
4 |
A multimodal approach to dementia prevention: A report from the Cambridge Institute of Public Health
|
Olanrewaju, Olawale |
|
2015 |
|
3 |
p. 151-156 6 p. |
artikel |
5 |
A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects
|
Lues, Inge |
|
2015 |
|
3 |
p. 182-195 14 p. |
artikel |
6 |
A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot Study
|
Deal, Jennifer A. |
|
2017 |
|
3 |
p. 410-415 6 p. |
artikel |
7 |
B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?
|
Tsiachristas, Apostolos |
|
2016 |
|
3 |
p. 156-161 6 p. |
artikel |
8 |
Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project
|
Kunneman, Marleen |
|
2017 |
|
3 |
p. 305-313 9 p. |
artikel |
9 |
Combined mnemonic strategy training and high-definition transcranial direct current stimulation for memory deficits in mild cognitive impairment
|
Hampstead, Benjamin M. |
|
2017 |
|
3 |
p. 459-470 12 p. |
artikel |
10 |
Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease
|
Peters, Oliver |
|
2015 |
|
3 |
p. 198-204 7 p. |
artikel |
11 |
Delayed-start analysis for demonstrating disease modification of solanezumab
|
Wolters, Frank J. |
|
2015 |
|
3 |
p. 196-197 2 p. |
artikel |
12 |
Determining the impact of psychosis on rates of false-positive and false-negative diagnosis in Alzheimer's disease
|
Fischer, Corinne E. |
|
2017 |
|
3 |
p. 385-392 8 p. |
artikel |
13 |
Diagnostic dilemmas in Alzheimer's disease: Room for shared decision making
|
van der Flier, Wiesje M. |
|
2017 |
|
3 |
p. 301-304 4 p. |
artikel |
14 |
First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease
|
Ferrero, James |
|
2016 |
|
3 |
p. 169-176 8 p. |
artikel |
15 |
Insufficient evidence for vitamin E in Alzheimer's disease
|
Hermann, Dirk M. |
|
2016 |
|
3 |
p. 199-201 3 p. |
artikel |
16 |
Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses
|
de Wilde, Martijn C. |
|
2017 |
|
3 |
p. 416-431 16 p. |
artikel |
17 |
Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults
|
Chuang, Yi-Fang |
|
2017 |
|
3 |
p. 471-479 9 p. |
artikel |
18 |
Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
|
Landen, Jaren W. |
|
2017 |
|
3 |
p. 339-347 9 p. |
artikel |
19 |
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
|
Lanctôt, Krista L. |
|
2017 |
|
3 |
p. 440-449 10 p. |
artikel |
20 |
NPT088 reduces both amyloid-β and tau pathologies in transgenic mice
|
Levenson, Jonathan M. |
|
2016 |
|
3 |
p. 141-155 15 p. |
artikel |
21 |
Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project
|
Kunneman, Marleen |
|
2017 |
|
3 |
p. 314-322 9 p. |
artikel |
22 |
Pharmocologic treatment with histone deacetylase 6 inhibitor (ACY-738) recovers Alzheimer's disease phenotype in amyloid precursor protein/presenilin 1 (APP/PS1) mice
|
Majid, Tabassum |
|
2015 |
|
3 |
p. 170-181 12 p. |
artikel |
23 |
Phase II clinical trials of anti–amyloid β antibodies: When is enough, enough?
|
Gold, Michael |
|
2017 |
|
3 |
p. 402-409 8 p. |
artikel |
24 |
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study
|
Landen, Jaren W. |
|
2017 |
|
3 |
p. 393-401 9 p. |
artikel |
25 |
Poor cerebrovascular function is an early marker of cognitive decline in healthy postmenopausal women
|
Wong, Rachel H.X. |
|
2016 |
|
3 |
p. 162-168 7 p. |
artikel |
26 |
Power analysis to detect treatment effects in longitudinal clinical trials for Alzheimer's disease
|
Huang, Zhiyue |
|
2017 |
|
3 |
p. 360-366 7 p. |
artikel |
27 |
Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor
|
Timmers, Maarten |
|
2016 |
|
3 |
p. 202-212 11 p. |
artikel |
28 |
Proof of concept demonstration of optimal composite MRI endpoints for clinical trials
|
Edland, Steven D. |
|
2016 |
|
3 |
p. 177-181 5 p. |
artikel |
29 |
Quantile regression to characterize solanezumab effects in Alzheimer's disease trials
|
Chen, Yun-Fei |
|
2016 |
|
3 |
p. 192-198 7 p. |
artikel |
30 |
Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health
|
Wheeler, Michael J. |
|
2017 |
|
3 |
p. 291-300 10 p. |
artikel |
31 |
Serum concentrations of vitamin E and carotenoids are altered in Alzheimer's disease: A case-control study
|
Mullan, Kathryn |
|
2017 |
|
3 |
p. 432-439 8 p. |
artikel |
32 |
Technology for home dementia care: A prototype locating system put to the test
|
Megges, Herlind |
|
2017 |
|
3 |
p. 332-338 7 p. |
artikel |
33 |
The BDNF Val66Met polymorphism moderates the effect of cognitive reserve on 36-month cognitive change in healthy older adults
|
Ward, David D. |
|
2017 |
|
3 |
p. 323-331 9 p. |
artikel |
34 |
The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease
|
Burfeind, Kevin G. |
|
2017 |
|
3 |
p. 348-359 12 p. |
artikel |
35 |
Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease
|
Boccardi, Virginia |
|
2016 |
|
3 |
p. 182-191 10 p. |
artikel |